Medical Research Fraud and Corruption_Cong. Sting_Forged Consents
Another research scam uncovered by the GAO sting involved a "bogus IRB with a pet dog as its CEO."
-
-
AstraZeneca Silenced Drug Study Creates Uproar_WashPost
Study 15 was pivotal to AstraZeneca gaining FDA approval to market Seroquel. The burial of negative data suggests that the approval process was tainted and the drug's license should be recalled.
-
Deaths, A Consequence of Forced Psychotropic Drugs
"Whatever powers the Constitution has granted our government, involuntary mind control is not one of them, absent extraordinary circumstances." 1979, Judge Joseph L. Tauro
-
US Organ Harvesting in “Not Yet Dead” patients
Are you aware that if you are in an accident in the U.S. your organs may be surgically removed without your consent?
-
AACAP President Disingenuous RE: Psychiatric Drugs that Killed 4-year old
This young child represents millions of children in the United States who are falling prey to licensed, but irresponsible prescribers of toxic drugs.
-
IRB Forum Not Inclined to Discuss the Most Serious Issue of All
Unssuccessful effort to engage debate within the community of the authorized clinical research gatekeepers charged with protecting the safety and welfare of the human subjects of research–i.e., members of institutional review boards (IRBs–REBs in Canada).
-
Dangerous Deception: Hiding the Evidence of Adverse Drug Effects_NEJM
FDA's slip-shod approval of defective, harmful drugs, accompanied by rubber stampped endorsements by compromised FDA advisory committees may be reaching a boiling point.
-
-
Psychiatrist Challenges Ethics of Yale Drug Experiment
The ethics of this radical drug experiment is being challenged by Dr. Jerald Block, a forthright psychiatrist and experienced system's analyst. His critical appraisal, published in the Bioethics Forum, Hastings Center Report.
-
Conflicts of Interest Hopkins Study: Researchers Don’t Want to Disclose $$
Two surveys confirm medical researchers' resistance to complying with conflict of interest disclosure requirements.
-
Maryland Lead Paint Appeal Denied
Maryland Court of Appeals Denies Motion to Reconsider Lead Paint Ruling October 10, 2001 FYI Maryland’s highest court denied the motion for reconsideration or partial modification of its Opinion–as requested by Kennedy Krieger Institute and their powerful allies in the research community (who filed Amicus briefs in support of defendants’…
-
Research Compliance Note. Thomas Dalglish, JD, PhD
Analysis of 94 OHRP Letters of Determination, July 1, 2000 to January 31, 2001 Research Compliance Note. Thomas Dalglish, JD, PhD * The views expressed in the ‘Research Compliance Note’ below are the personal opinions of the author, do not reflect any official position of the University of Washington, and…